Use of hydroxychloroquine and azithromycin combination to treat the COVID-19 infection

doi:10.5493/wjem.v12.i3.44

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5789)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

268

WORD

153

HTML

2611

Figures (1-2)

276

Tables (1-2)

268

Sum=3576

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

221

Download

860

Sum=1081

Publishing Process of This Article

Item

Count

Browse

343

Download

789

Sum=1132

May 20, 2022 (publication date) through Nov 12, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Experimental Medicine

ISSN

2220-315x

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Exp Med. May 20, 2022; 12(3): 44-52
Published online May 20, 2022. doi: 10.5493/wjem.v12.i3.44

Full Size Figure Download Figure

Figure 2 Risk factors for hydroxychloroquine-induced arrhythmia.

Citation: Bajpai J, Pradhan A, Verma AK, Kant S. Use of hydroxychloroquine and azithromycin combination to treat the COVID-19 infection. World J Exp Med 2022; 12(3): 44-52
URL: https://www.wjgnet.com/2220-315x/full/v12/i3/44.htm
DOI: https://dx.doi.org/10.5493/wjem.v12.i3.44